1,000+ Opportunities

Find the right grant

Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.

This listing may be outdated. Verify details at the official source before applying.

Find similar grants

ActiveU.S. Food and Drug Administration (FDA) · 2026

Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (R01) Clinical Trial Not Allowed

Quick Facts

Agency: U.S. Food and Drug Administration (FDA)
Funding: No Information
Deadline: Check Source
Status: Active
Eligibility: Universities and other research institutions are eligible.

About This Grant

Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (R01) Clinical Trial Not Allowed is sponsored by U.S. Food and Drug Administration (FDA). This opportunity supports mission-aligned projects and measurable outcomes.

View Original RFP

Get a weekly digest of new grants like this

A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.

Or search similar grants →

Official Opportunity Details

Extracted from the official opportunity page/RFP to help you evaluate fit faster.

A **. gov** website belongs to an official government organization in the United States.

* How to Apply for Grants * **Applicant Resources** * Adobe Software Compatibility * Submitting UTF-8 Special Characters * Encountering Error Messages * Grantor Standard Language * Submitting UTF-8 Special Characters * **Applicant System-To-System** * Reference Implementation * **Grantor System-To-System** * Reference Implementation * SF-424 Individual Family * SF-424 Mandatory Family * SF-424 Short Organization Family * Post-Award Reporting Forms * Country and State Lists Updates * **Manage Subscriptions** * Program Management Office * Grants.

gov Maintenance Calendar Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (R01) Clinical Trials Not Allowed Department of Health and Human Services Food and Drug Administration Document Type:Grants Notice Funding Opportunity Number:RFA-FD-21-033 Funding Opportunity Title:Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (R01) Clinical Trials Not Allowed Opportunity Category:Discretionary Opportunity Category Explanation: Funding Instrument Type:Cooperative Agreement Category of Funding Activity:Agriculture Expected Number of Awards:4 Assistance Listings:93.

103 -- Food and Drug Administration Research Cost Sharing or Matching Requirement:No Last Updated Date:Mar 14, 2021 Original Closing Date for Applications:May 18, 2021 Current Closing Date for Applications:May 18, 2021 Archive Date:Jun 17, 2021 Estimated Total Program Funding:$ 2,000,000 Eligible Applicants:Small businesses Native American tribal governments (Federally recognized) Others (see text field entitled "Additional Information on Eligibility" for clarification) Public housing authorities/Indian housing authorities Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments For profit organizations other than small businesses Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Private institutions of higher education Additional Information on Eligibility:Higher Education InstitutionsPublic/State Controlled Institutions of Higher Education Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education: o Hispanic-serving Institutionso Historically Black Colleges and Universities (HBCUs)o Tribally Controlled Colleges and Universities (TCCUs) o Alaska Native and Native Hawaiian Serving Institutionso Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)Nonprofits Other Than Institutions of Higher EducationNonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) For-Profit OrganizationsSmall Businesses For-Profit Organizations (Other than Small Businesses) GovernmentsState Governments County Governments City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Recognized) U.S. Territory or Possession OtherIndependent School Districts Public Housing Authorities/Indian Housing Authorities Native American Tribal Organizations (other than Federally recognized tribal governments) Faith-based or Community-based Organizations Regional Organizations ## Additional Information Agency Name:Food and Drug Administration Description:CBER seeks to support several research projects that are focused on developing novel technologies for the advanced manufacturing of complex biologic products or innovative analytical approaches for improving product manufacturing and quality.

Link to Additional Information:Full Announcement of RFA-FD-21-033 on NIH Guide for Grants and Contracts Grantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact: Grant Management Specialist gordana. zuber@fda. hhs.

gov #### Health & Human Services * Frequently Asked Questions ## Your session will expire in 3 minutes. To continue working, click on the "OK" button below. This is being done to protect your privacy.

Unsaved changes will be lost.

Eligibility Requirements

Universities and other research institutions are eligible.

Frequently Asked Questions

Who can apply for Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (R01) Clinical Trial Not Allowed?

According to the current listing, eligibility includes: Universities and other research institutions are eligible. Confirm the full requirements in the official notice before applying.

Who funds Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (R01) Clinical Trial Not Allowed?

Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (R01) Clinical Trial Not Allowed is funded by U.S. Food and Drug Administration (FDA). Verify program details on the funder's official page before applying.

How do I apply for Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (R01) Clinical Trial Not Allowed?

Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.

Funder Profile

Ready to start your proposal?

Granted drafts, reviews, and strengthens your grant application — saving weeks of work. Professional members win a grant in 12 months or get a full refund.

Browse More Grants

Backed by the Granted Guarantee

Related Grants

U.S. Food and Drug Administration (FDA)

DiscoveredActive

Food and Drug Administration Research (for Minor Use/Minor Species Animal Drugs)

Food and Drug Administration Research (for Minor Use/Minor Species Animal Drugs) is sponsored by U.S. Food and Drug Administration (FDA). The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of animal drugs intended for minor uses in major species or for use in minor species (MUMS).

Not specifiedDeadline: Jan 29, 2027

U.S. Food and Drug Administration (FDA) Grant Writing Tips

Virginia's Fall AFID Round Opened September 14 With a $50,000 Ceiling — and the Farmer Who Needs the Money Cannot Be the Applicant

The AFID Infrastructure Grant program closes October 30, 2026. Awards top out at $50,000, they are reimbursable, and only a political subdivision can apply. The August round put $507,000 into 14 projects at an average of about $36,000.

Read article

USDA Put $7.5 Million Into Food Bank Freezers. Almost No Food Bank Can Apply for It.

The Cold Chain Grants for Emergency Food Assistance Program closes October 1, 2026, funding cold storage equipment at up to $200,000 per project with a 10% cash match. But USDA is not awarding to food banks — it is awarding to nonprofit intermediaries who will run competitive subaward programs. Two audiences, two entirely different jobs, and one of them has 43 days.

Read article

Missouri's Urban Agriculture Cost-Share Grant Reopens: How a $10,000 75% Reimbursement Fits Into the 2026 Urban Farming Funding Stack

Missouri's Department of Agriculture has reopened its Urban Agriculture Cost-Share Grant — reimbursing 75% of project costs up to $10,000, with applications due September 15, 2026. A companion Food Insecure Cost-Share Grant closes August 26. Here is how these small, fast state grants work, who qualifies under the Census 'urban area' definition, and how to layer them with the federal USDA Urban Agriculture and Innovative Production program for a durable urban-farming funding strategy.

Read article